Expand AGIO Menu
AGIO MENU

AGIO Latest Press Releases

-- December 8, 2025 --

Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia Globe Newswire 7:00 AM

-- November 19, 2025 --

Agios Announces Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease Globe Newswire 7:00 AM

-- November 3, 2025 --

Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition Globe Newswire 9:01 AM

-- October 30, 2025 --

Agios Reports Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 6:30 AM

-- October 18, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO PRNewswire 10:00 AM

-- October 17, 2025 --

Avanzanite Bioscience's Partner Agios Announces Positive CHMP Opinion for PYRUKYND (mitapivat) for Adults with Thalassemia Business Wire 8:15 AM
Agios' PYRUKYND (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia Globe Newswire 8:00 AM

-- October 16, 2025 --

Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October 30 at 8:00 a.m. ET Globe Newswire 7:00 AM

-- October 13, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO PRNewswire 1:43 PM

-- October 8, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO PRNewswire 5:44 PM

-- October 3, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO PRNewswire 10:00 AM

-- September 28, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO PRNewswire 10:01 AM

-- September 24, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO Globe Newswire 4:38 PM

-- September 23, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO PRNewswire 10:00 AM

-- September 18, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO PRNewswire 10:00 AM
AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm PRNewswire 5:49 AM

-- September 15, 2025 --

AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation With the Schall Law Firm Business Wire 12:20 PM

-- September 13, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO PRNewswire 12:30 PM

-- September 10, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO Globe Newswire 2:20 PM

-- September 8, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO PRNewswire 3:00 PM

-- September 4, 2025 --

Agios Provides Update on U.S. PDUFA Goal Date for PYRUKYND (mitapivat) in Thalassemia Globe Newswire 7:00 AM

-- August 4, 2025 --

Agios' PYRUKYND (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia Globe Newswire 4:01 PM

-- July 31, 2025 --

Agios Reports Second Quarter 2025 Financial Results and Provides Business Update Globe Newswire 6:30 AM
Market Data Delayed 15 Minutes